Target intelligence / Profile preview

Mechanistic target of rapamycin complex 1 signaling pathway (mTORC1 signaling pathway)

Target
mTORC1 signaling pathway
Molecular classification
Other (Signaling pathway), Protein complex (for mTORC1 as a component), Enzyme (for mTOR kinase within the complex)
01

Overview

The mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway integrates signals from amino acids—primarily leucine—as well as energy and growth factors to regulate cell growth, proliferation, and metabolism.[4][1] Leucine activates mTORC1 through direct mechanisms (via sensing by Sestrin2 and leucyl-tRNA synthetase)[4][2] and indirectly via its metabolism to acetyl-CoA, which further regulates mTORC1 activity in a cell-type-specific manner[3]. mTORC1 coordinates protein synthesis, cell growth, and metabolic adaptation, and its dysregulation is linked to cancer, metabolic disease, and age-related pathologies. While mTORC1 itself is a major drug target, the pathway described here encompasses both upstream metabolic events (leucine metabolism) and downstream signaling; thus, as a whole, it is not a single molecular target but rather a critical regulatory network.

Other names
mTOR signaling pathwaymTORC1 pathwayLeucine-stimulated mTORC1 signalingLeucine-mTOR pathway
02

Mechanism of action

Inhibition of mTOR kinase activity (suppresses protein synthesis and cell growth) and indirect modulation via amino acid mimetics or leucine analogues (modulates leucine sensing and thus mTORC1 activation).

03

Biological functions

Signal transductionCell growthCell proliferationProtein synthesis regulationMetabolic regulation
04

Disease associations

CancerMetabolic disordersMuscle wasting/cachexiaDiabetes/metabolic syndromeOther (e.g., neurodegenerative diseases, cardiovascular disease)
05

Safety considerations

Immunosuppression (for mTOR inhibitors)Impaired wound healingDyslipidemiaGlucose metabolism disturbance/insulin resistancePotential muscle loss if pathway is over-inhibited
06

Interacting drugs

Rapamycin (and analogs/rapalogs)

4 more in the full profile.

07

Biomarkers

Phosphorylated S6 kinase 1 (S6K1)Phosphorylated 4EBP1mTORC1 activation state (measured by downstream substrate phosphorylation)Leucine levels (for metabolic assessment)

Beyond the preview

Go deeper on Mechanistic target of rapamycin complex 1 signaling pathway (mTORC1 signaling pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mechanistic target of rapamycin complex 1 signaling pathway (mTORC1 signaling pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call